[
    {
        "title": "Higher SII Levels Indicate Higher COPD Prevalence, All-Cause ... - AJMC.com Managed Markets Network",
        "description": "Higher SII Levels Indicate Higher COPD Prevalence, All-Cause ...  AJMC.com Managed Markets Network",
        "published date": "Fri, 18 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvaGlnaGVyLXNpaS1sZXZlbHMtaW5kaWNhdGUtaGlnaGVyLWNvcGQtcHJldmFsZW5jZS1hbGwtY2F1c2UtbW9ydGFsaXR5LXJpc2vSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Tracking Physical Activity in Patients With ILD Lacks Consistency - AJMC.com Managed Markets Network",
        "description": "Tracking Physical Activity in Patients With ILD Lacks Consistency  AJMC.com Managed Markets Network",
        "published date": "Fri, 18 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvdHJhY2tpbmctcGh5c2ljYWwtYWN0aXZpdHktaW4tcGF0aWVudHMtd2l0aC1pbGQtbGFja3MtY29uc2lzdGVuY3nSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Ociperlimab Plus Tislelizumab/Chemo Has Antitumor Activity in ... - OncLive",
        "description": "Ociperlimab Plus Tislelizumab/Chemo Has Antitumor Activity in ...  OncLive",
        "published date": "Fri, 18 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvb2NpcGVybGltYWItcGx1cy10aXNsZWxpenVtYWItY2hlbW8taGFzLWFudGl0dW1vci1hY3Rpdml0eS1pbi1zdGFnZS1pdi1nYXN0cmljLWdlai1jYW5jZXJz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Olaparib With High-Dose Chemo and ASCT Shows Potential in R/R ... - Targeted Oncology",
        "description": "Olaparib With High-Dose Chemo and ASCT Shows Potential in R/R ...  Targeted Oncology",
        "published date": "Fri, 18 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L29sYXBhcmliLXdpdGgtaGlnaC1kb3NlLWNoZW1vLWFuZC1hc2N0LXNob3dzLXBvdGVudGlhbC1pbi1yLXItbHltcGhvbWFz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "EV-103 Study Highlights Promise of Enfortumab Vedotin and ... - Targeted Oncology",
        "description": "EV-103 Study Highlights Promise of Enfortumab Vedotin and ...  Targeted Oncology",
        "published date": "Fri, 18 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2V2LTEwMy1zdHVkeS1oaWdobGlnaHRzLXByb21pc2Utb2YtZW5mb3J0dW1hYi12ZWRvdGluLWFuZC1wZW1icm8taW4tbXVj0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]